Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)

• DOI: 10.1016/j.eururo.2023.06.018
• Publication Date: 2023-07-05T05:04:03Z
• Authors: Devaki Shilpa Surasi; Matthias Eiber; Tobias Maurer; Mark A. Preston; Brian T. Helfand; David Josephson; Ashutosh K. Tewari; Diederik M. Somford; Soroush Rais-Bahrami; Bridget F. Koontz; Peter J. Bostrom; Albert Chau; Phillip Davis; David M. Schuster; Brian F. Chapin; Mohamad Allaf; Gerald Andriole; Ryan J. Avery; Norbert Avril; Helen Barker; Laurence Belkoff; Lars Budäus; Michael L. Cher; Diane Chisholm; Matthew F. Covington; Ian Cox; Michael Ferrandino; Mark T. Fleming; Dinko Franceschi; Peter Gardiner; Benjamin Gartrell; David Gauden; Ergela Hasa; Rick Hermsen; Thomas Horn; Pooya Iranpour; Heather Jacene; Isuru Jayaratna; Shreyas S. Joshi; Matthew Kay; Lale Kostakoglu; Phillip Kuo; William Lavely; Mary Lokuta; Benjamin Lowentritt; Matthew P. Miller; Jeffrey W. Nix; Kenneth Ogan; Ross Penny; Morand Piert; Andrei Purysko; Gregory Ravizzini; Daniel Saltzstein; Bital Savir-Baruch; Barry A. Siegel; Thomas Steuber; Przemyslaw Twardo...; Edward Uchio; Gary A. Ulaner; Jenna M. Wixom; Don Yoo; Katherine Zukotynski
• Keywords: Histopathology

Radiohybrid (rh)